Bioxytran Statistics

Total Valuation

Bioxytran has a market cap or net worth of 6.81 million. The enterprise value is 7.74 million.

Market Cap	6.81M
Enterprise Value	7.74M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Bioxytran has 85.78 million shares outstanding. The number of shares has increased by 19.23% in one year.

Current Share Class	n/a
Shares Outstanding	85.78M
Shares Change (YoY)	+19.23%
Shares Change (QoQ)	-28.43%
Owned by Insiders (%)	0.58%
Owned by Institutions (%)	16.35%
Float	85.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.75
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-40.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-996.63%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-936,412
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.07% in the last 52 weeks. The beta is -0.54, so Bioxytran's price volatility has been lower than the market average.

Beta (5Y)	-0.54
52-Week Price Change	-39.07%
50-Day Moving Average	0.09
200-Day Moving Average	0.10
Relative Strength Index (RSI)	48.62
Average Volume (20 Days)	187,854

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.78M
Pretax Income	-2.84M
Net Income	-2.81M
EBITDA	-2.77M
EBIT	-2.78M
Earnings Per Share (EPS)	-0.02

Full Income Statement

Balance Sheet

The company has 34,672 in cash and 933,588 in debt, giving a net cash position of -898,916 or -0.01 per share.

Cash & Cash Equivalents	34,672
Total Debt	933,588
Net Cash	-898,916
Net Cash Per Share	-0.01
Equity (Book Value)	-1.08M
Book Value Per Share	-0.01
Working Capital	-1.21M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-190,673
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bioxytran does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.23%
Shareholder Yield	-19.23%
Earnings Yield	-23.20%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a